ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Ascendis Pharma A/S (ASND) shows an Average True Range (ATR) of 6.58 and an Enterprise Value of 7.82B. Its average trading volume over the past 3 months is 450.33K, indicating liquidity. These fundamental metrics provide insight into ASND's underlying financial health and market activity.
Ascendis Pharma A/S (ASND) technical indicators as of August 2, 2025: the SMA 20 is 1.88%, SMA 50 at 2.1%, and SMA 200 at 17.13%. The RSI 14 value is 55.63, suggesting its current momentum. These technical analysis signals help assess ASND's price trends and potential future movements.
Ascendis Pharma A/S (ASND) stock performance overview as of August 2, 2025: The 52-week high is $183 (currently -4.66% below), and the 52-week low is $111.09 (currently 57.06% above). Over the past year, ASND's performance is 29.97%, compared to the S&P 500's 14.53% change.
According to market data, Ascendis Pharma A/S (ASND) stock's recent performance metrics show that over the last month, ASND is 0.8%, with a Year-to-Date (YTD) performance of 26.74%. Over the past year, the stock has seen a 29.97% change. These figures summarize ASND's price movements across various periods, reflecting its historical returns.
According to current financial data, ASND stock's P/E (TTM) ratio is -26.56, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for ASND, including P/S (24.76), P/B (-47.81), and P/FCF (-41.34), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.